EXOZ eXoZymes Inc.

$EXOZ This company is worth $0. They could barely close an equity raise, they cut size and price.

$EXOZ when will this company gain traction? Are revenues expected this year? Sorry i havent been keeping up. A summary of the past 6 months will be appreciated

$EXOZ | Technical Setup 📉🧪 • Structure: $EXOZ coiling inside a multi-month falling wedge following a drop to major base support near $4.35–$5.00. Price is bouncing off lower channel support and compressing toward key horizontal volume shelf levels. • Catalyst: Synthetic biomanufacturing platform expansion and NIH grant funding advancing cannabinoid analog drug discovery programs. 🎯 Key Levels: 🐂 Bull Trigger: $6.70 / $10.25 🚀 Targets: $11.60 / $14.10 / $18.40 🛡️ Support: $6.00 / $5.00 ⚠️ Risk: $4.35 / $3.50 #EXOZ #stocks #trading #biotech #hovdid

$EXOZ | Fundamental & Technical Breakdown 📊🧪 • Business Overview: Development-stage synthetic biology company focused on enzymatic platforms for scalable biological molecule discovery. • Profitability & Financials: Unprofitable. Early-stage micro-cap company with no active commercial revenue, operating with net losses (~-$1.20 EPS). • Latest Earnings Report: Missed/Unprofitable (Reported EPS of -$0.33 with zero revenue). • Wall Street Analyst Consensus: Unrated / Low Coverage. Limited institutional analyst coverage given small market cap (~$57M). • Overall Bias: Cautiously Speculative / Bottoming Watch (Technicals compressing in a falling wedge near $6.10 support; breakout triggers above $7.50). Key Levels for Bulls & Bears: • Bull Reclaim Trigger: $7.50 / $8.20 • Overhead Targets: $9.10 / $10.15 • Critical Support Pivot: $6.10 • Bearish Invalidation Level: $5.90 / $4.35 #EXOZ #biotech #smallcaps #fundamentalanalysis #hovdid